@FierceBiotech: Who thinks they've got the tonic for Big Pharma social media headaches? This guy does: Piece | Follow @FierceBiotech
@JohnCFierce: VC boom: U.K. charity births $80M biotech fund for cancer drug research--I count $730M in new U.K./euro funds this month. Story | Follow @JohnCFierce
@RyanMFierce: Moscow backs clones of Western biotech programs in Russia. More | Follow @RyanMFierce
@FierceMedDev: Roche raises bid for U.S. diagnostics firm Illumina - San Jose Mercury News. Article | Follow @FierceMedDev
> Japan's Kyowa Hakko Kirin and Fujifilm have initiated their biosimilars joint venture, with an initial focus on Abbott's ($ABT) Humira. Story
> Seattle's Accelerator has tapped David McElligott as its new CSO. He replaces Patrick Gray, who took a position at Omeros. News
> Now that DBV Technologies has priced its shares, France has recorded its fourth healthcare IPO in the quarter, the most for any quarter in at least 20 years. Story
> Nile Therapeutics says its Phase I study for an experimental heart drug met its endpoint. Report
Pharma News
@FiercePharma: Who could make a play for Amylin next? AstraZeneca and Sanofi, per analysts. Bristol-Myers may return, too. Article | Follow @FiercePharma
> Allergan asks FDA for lucrative new Botox indication. Item
> Judge denies AZ's bid to stop Seroquel copies, but chides FDA. News
> Who's next to move on Amylin? Analysts say Big Pharma looms. Story
CRO News
> Parexel should see more revenue, higher share prices, analysts say. More
> Cetero sees strong future despite bankruptcy protection filing. Article
> INC Research axes staffers, closes Connecticut lab. Story
> Spaulding's hand-held ECG fuels tax credits and hiring boom. Item
> Report sheds light on pharma and CRO trial enrollment woes. News
Vaccines News
> Vaxfectin-based malaria vaccine could stop transmission. Item
> Narcolepsy spike linked with flu shot. Story
> Academics' oral stomach flu vax could save lives. Article
> Genetic tweaking could create chlamydia vaccine. More
Manufacturing News
> CMC, third-party manufacturing issues delay Map drug launch. News
> California implant makers get FDA warnings. Article
> Novartis plant disruptions affect pet treatments. Story
> Sandoz Canada president explains shortages to House of Commons. Article
> Halo agrees to buy Teva's Montreal facility. Report
And Finally… An international group of investigators is working on a new "micro-robot" designed to detect diseases. Release